EH
ABBV icon

Equitable Holdings’s AbbVie ABBV Stock Holding History

Equitable Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24M Sell
95,431
-4,782
-5% -$1.03M 0.14% 145
2026
Q1 		$22.7M Buy
100,213
+21,094
+27% +$4.68M 0.15% 136
2025
Q4 		$18.1M Buy
79,119
+14,113
+22% +$3.21M 0.12% 150
2025
Q3 		$15.1M Buy
65,006
+2,257
+4% +$460K 0.11% 168
2025
Q2 		$11.6M Sell
62,749
-746
-1% -$139K 0.1% 181
2025
Q1 		$13.3M Buy
63,495
+1,613
+3% +$314K 0.13% 144
2024
Q4 		$11M Buy
61,882
+6,602
+12% +$1.21M 0.1% 164
2024
Q3 		$10.9M Sell
55,280
-5,545
-9% -$1.03M 0.11% 162
2024
Q2 		$10.4M Buy
60,825
+3,351
+6% +$555K 0.11% 157
2024
Q1 		$10.5M Buy
57,474
+3,361
+6% +$579K 0.12% 146
2023
Q4 		$8.39M Buy
54,113
+6,069
+13% +$885K 0.1% 156
2023
Q3 		$7.16M Buy
48,044
+8,163
+20% +$1.2M 0.1% 155
2023
Q2 		$5.37M Buy
39,881
+10,385
+35% +$1.52M 0.08% 183
2023
Q1 		$4.7M Buy
29,496
+7,429
+34% +$1.14M 0.08% 182
2022
Q4 		$3.57M Buy
22,067
+283
+1% +$43.4K 0.06% 199
2022
Q3 		$2.92M Buy
21,784
+600
+3% +$86.1K 0.06% 213
2022
Q2 		$3.25M Sell
21,184
-1,903
-8% -$291K 0.06% 198
2022
Q1 		$3.74M Sell
23,087
-4,785
-17% -$695K 0.06% 192
2021
Q4 		$3.77M Sell
27,872
-114
-0.4% -$13.5K 0.06% 197
2021
Q3 		$3.02M Buy
27,986
+2,184
+8% +$250K 0.05% 208
2021
Q2 		$2.91M Sell
25,802
-931
-3% -$105K 0.05% 204
2021
Q1 		$2.89M Buy
26,733
+992
+4% +$106K 0.06% 184
2020
Q4 		$2.76M Sell
25,741
-1,948
-7% -$187K 0.06% 185
2020
Q3 		$2.42M Buy
27,689
+654
+2% +$61.6K 0.06% 181
2020
Q2 		$2.65M Buy
27,035
+10,436
+63% +$919K 0.08% 158
2020
Q1 		$1.26M Sell
16,599
-13,011
-44% -$1.11M 0.05% 232
2019
Q4 		$2.62M Buy
+29,610
New +$2.46M 0.08% 154

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Equitable Holdings's ABBV Position: Q2 2026 in Review

Equitable Holdings reduced its AbbVie (ABBV) stake by 4.8% in Q2 2026, selling an estimated $1.03M and leaving 95,431 shares worth $24M. The position accounts for 0.14% of the portfolio, ranked #145.

Equitable Holdings first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Equitable Holdings held 95,431 shares of AbbVie worth $24M as of Q2 2026.
  • Equitable Holdings sold 4,782 AbbVie shares in Q2 2026, an estimated $1.03M.
  • AbbVie made up 0.14% of Equitable Holdings's portfolio in Q2 2026, its #145 holding.
  • Equitable Holdings first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.